Selected article for: "sample size and test sensitivity"

Author: Daniel B Larremore; Bailey K Fosdick; Kate M Bubar; Sam Zhang; Stephen M Kissler; C. Jessica E. Metcalf; Caroline Buckee; Yonatan Grad
Title: Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
  • Document date: 2020_4_20
  • ID: c4cs14ja_11
    Snippet: The credible interval in the resulting overall seroprevalence estimates were influenced by the age demographics sampled, with the most uncertainty in the newborn dried blood spots sample set, due to the narrow age range for the mothers (Fig. 3 ). For such sampling strategies, which draw from only a subset of the population, our mathematical approach assumes that seroprevalence in each subpopulation does not dramatically vary and thus infers that .....
    Document: The credible interval in the resulting overall seroprevalence estimates were influenced by the age demographics sampled, with the most uncertainty in the newborn dried blood spots sample set, due to the narrow age range for the mothers (Fig. 3 ). For such sampling strategies, which draw from only a subset of the population, our mathematical approach assumes that seroprevalence in each subpopulation does not dramatically vary and thus infers that seroprevalence in the unsampled bins is similar to that in the sampled bins but with increased uncertainty (Methods; Supplementary Text). Uncertainty was also influenced by the overall seroprevalence, such that the width of the 90% credible interval increased with higher seroprevalence for a given sample size. While test sensitivity and specificity also impacted uncertainty, central estimates of overall seropositivity were robust for sampling strategies that spanned the entire population.

    Search related documents:
    Co phrase search for related documents
    • high seroprevalence and overall seroprevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • high seroprevalence and sample size: 1, 2, 3
    • high seroprevalence and seroprevalence estimate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • high seroprevalence and specificity test sensitivity: 1, 2, 3, 4
    • high seroprevalence and test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • increase uncertainty and sample size: 1
    • increase uncertainty and uncertainty impact: 1, 2, 3, 4, 5
    • sample size and seroprevalence estimate: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • sample size and specificity test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8
    • sample size and subpopulation seroprevalence: 1
    • sample size and test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • sampling strategy and seroprevalence estimate: 1, 2
    • sampling strategy and specificity test sensitivity: 1, 2
    • sampling strategy and test sensitivity: 1, 2, 3, 4
    • seroprevalence estimate and specificity test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • seroprevalence estimate and test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • specificity test sensitivity and subpopulation seroprevalence: 1
    • specificity test sensitivity and test sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79
    • subpopulation seroprevalence and test sensitivity: 1